Strides Pharma Science (STAR) Share Price Falls 5%: What the Stock Move Means
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Strides Pharma Science Share Price is trading at Rs 1,112 after a 5% decline today, with the company valued at Rs 10,612.31 crore. According to Univest data, the move is a price fall rather than a broader trend conclusion, and no company-specific catalyst is established. For readers tracking Strides Pharma Science Share Price Today, the key point is that the stock opened at Rs 1,171.35, touched a high of Rs 1,174.15 and a low of Rs 1,110, and remains a Mid Cap healthcare name in current market terms. Strides Pharma Science Share Price News therefore centres on the price action itself, the valuation backdrop, and how the stock sits within Pharmaceuticals & Drugs on the latest Univest figures. Should investors track Strides Pharma Science Share Price? The answer depends on how they weigh the current ratios against sector context.
Strides Pharma Science (STAR) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,112 |
| Previous Close | Rs 1,170.5 |
| Today's Move | -Rs 58.50 (-5%) |
| Open | Rs 1,171.35 |
| High | Rs 1,174.15 |
| Low | Rs 1,110 |
| Market Capitalisation | Rs 10,612.31 crore |
| Market Cap Category | Mid Cap |
Strides Pharma Science Share Price Today shows a clear single-session decline from the previous close of Rs 1,170.50 to Rs 1,112, a fall of Rs 58.50 or 5%. The stock opened almost in line with the prior level at Rs 1,171.35, but then moved between Rs 1,174.15 and Rs 1,110 during the session. That placed Strides Pharma Science Share Price near the lower end of the day’s range as of 30 September 2026 at 3:33:26 PM IST. Market capitalisation stood at Rs 10,612.31 crore, which keeps the company in the Mid Cap category. For investors following Strides Pharma Science Share Price Live, the day’s data confirms the move, but not a cause. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes the stock a price-action story first, with fundamentals next in line.
Strides Pharma Science (STAR) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 10,612.31 crore |
| P/E Ratio | 17.59x |
| P/B Ratio | 3.3x |
| ROE | 20.31% |
| ROCE | 18.57% |
| EPS | Rs 66.56 |
| Book Value Per Share | Rs 355.18 |
| Dividend Yield | 0.43% |
Strides Pharma Science (STAR) fundamental metrics show P/E 17.59x, P/B 3.3x, ROE 20.31%, ROCE 18.57%. These figures provide context only and are not a buy or sell signal.
Strides Pharma Science has a market capitalisation of Rs 10,612.31 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 17.59x, P/B at 3.3x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.31% and ROCE of 18.57%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 66.56, book value per share of Rs 355.18, dividend yield of 0.43%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.43x, median ROE of 11.7%, median ROCE of 13.61%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 17.59x |
| Benchmark Median P/E | 32.43x |
| Benchmark Average P/E | 49.46x |
| Benchmark P/E Range | 3.4x to 699.02x |
| Company P/B Ratio | 3.3x |
| Benchmark Median P/B | 2.89x |
| Benchmark Average P/B | 4.38x |
| Company ROE | 20.31% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 18.57% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 10,612.31 crore |
| Benchmark Median Market Cap | Rs 776.09 crore |
| Benchmark Average Market Cap | Rs 14,255.4 crore |
Strides Pharma Science (STAR) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Strides Pharma Science (STAR) has a P/E ratio of 17.59x, which is below the benchmark median of 32.43x, a difference of -45.76%. On its own, the P/E gap is a valuation reference point, not a trading call.
Strides Pharma Science (STAR) has a ROE of 20.31%, which is above the benchmark median of 11.7%, a difference of +73.59%. Strides Pharma Science (STAR) has a ROCE of 18.57%, which is above the benchmark median of 13.61%, a difference of +36.44%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,41,477.63 | 36.9 | 5.16 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,031.38 | 85.99 | 14.24 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,85,216.32 | 85.72 | 20.83 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,20,897.46 | 26.42 | 4.42 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,205.15 | 33.15 | 3.18 | 11.83 | 16 |
Strides Pharma Science (STAR) has a P/E ratio of 17.59x compared with the displayed peer median of 36.9x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 20.31% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 18.57% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Strides Pharma Science (STAR) has a market capitalisation of Rs 10,612.31 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Strides Pharma Science
- Strides Pharma Science Share Price fell 5% today, making the move visible in Strides Pharma Science Share Price Today and Strides Pharma Science Stock News.
- The stock is a Mid Cap healthcare name with a market capitalisation of Rs 10,612.31 crore.
- Its P/E of 17.59 sits below the industry median and average in the same industry benchmark.
- ROE of 20.31% and ROCE of 18.57% compare favourably with the sector midpoint.
- Peer comparison shows a lower valuation than several larger pharmaceutical names in the set.
About Strides Pharma Science
Strides Pharma Science operates in Healthcare and the Pharmaceuticals & Drugs industry. The business context relevant to Strides Pharma Science Share Price is that of a listed pharmaceutical company evaluated through earnings, book value and return ratios. In this note, the latest Univest data supports a valuation and sector discussion rather than a product-by-product breakdown. For readers following Strides Pharma Science Share Price News, the important points are its Mid Cap profile, its position within a large industry benchmark, and the fact that its return ratios are above the central industry reference levels. That makes Strides Pharma Science Share Price relevant for investors who monitor company financials, sector analysis and valuation discipline together. The latest Univest figures also show that the stock remains part of the broader Healthcare set, where peer comparison often shapes how a market views relative pricing.
Track Strides Pharma Science Share Price on Univest
Use Strides Pharma Science (STAR) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Investors tracking Strides Pharma Science Share Price can use Univest to monitor the live share price, key ratios, 52-week levels and market insights in one place. Univest also helps readers compare Strides Pharma Science Share Price Today with sector peers, recent price action and fundamental analysis. For anyone following Strides Pharma Science Stock News or Strides Pharma Science Share News, that makes the stock easier to review alongside valuation and company context. The latest Univest figures are useful for building a clearer view of Strides Pharma Science Share Price without relying on scattered market commentary.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Strides Pharma Science Share Price fall today?
Ans. Strides Pharma Science Share Price fell 5% today to Rs 1,112 from Rs 1,170.50. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The intraday range extended from Rs 1,110 to Rs 1,174.15.
What is Strides Pharma Science Share Price Today?
Ans. Strides Pharma Science Share Price Today is Rs 1,112. The stock opened at Rs 1,171.35, touched a high of Rs 1,174.15 and a low of Rs 1,110 during the session.
What is the market capitalisation of Strides Pharma Science?
Ans. Strides Pharma Science has a market capitalisation of Rs 10,612.31 crore. The company is classified as a Mid Cap name in this note, which gives size context for Strides Pharma Science Share Price.
How is Strides Pharma Science Share Price valued?
Ans. Strides Pharma Science Share Price trades at a P/E of 17.59 and a P/B of 3.3. EPS is Rs 66.56, book value is Rs 355.18 and dividend yield is 0.43%.
How do the returns look for Strides Pharma Science?
Ans. The company reports ROE of 20.31% and ROCE of 18.57%. Those figures are above the benchmark median in the same industry and add context to Strides Pharma Science Share Price.
How does Strides Pharma Science compare with sector peers?
Ans. Strides Pharma Science Share Price is valued below several larger pharmaceutical peers on P/E, including Sun Pharma, Divi's Laboratories and Torrent Pharmaceuticals, while its return ratios remain competitive versus many listed names.
What does Strides Pharma Science Share News suggest for investors?
Ans. Strides Pharma Science Share News today is centred on a 5% price fall and a valuation read that sits below the industry median P/E. Investors can use that for context, not prediction.
Should investors track Strides Pharma Science Share Price on Univest?
Ans. Yes. Univest lets readers track Strides Pharma Science Share Price, key valuation ratios, sector context and peer comparison in one place, which is useful when a stock moves sharply in a single session.
